Dr. Sluder joined VIC in 2015 with a focus on discovery and development projects that connect basic science outcomes to therapeutic solutions, often in collaboration with other academic and industry partners. She also manages VIC finances, and works with other members of the VIC management team on strategic program initiatives.
Before coming to VIC, Dr. Sluder spent 15 years in industry, leading therapeutic discovery and early development programs for diverse indications, including anti- infectives, parasitic infections, and orphan neuromuscular diseases. She directed multiyear external research alliances with corporate and academic partners in the US, Europe, and Japan, and has worked cross-functionally in business development, intellectual property management, finance, and regulatory compliance. Prior to moving to industry Dr. Sluder was an Assistant Professor of Cellular Biology at the University of Georgia.
Dr. Sluder has served on grant and program review panels for the NIH, the World Health Organization, and the Coalition for Epidemic Preparedness Innovation. She is a co-chair of the Nonprofit Forum Working Group at the Massachusetts Biotechnology Council. Dr. Sluder is a co-founder and steering committee member for an alumni organization providing undergraduate research fellowships in the basic sciences at Emory & Henry College, and currently serves on the E&H Board of Trustees.
- BS; Biology & Chemistry (double major); Emory & Henry College
- PhD; Biochemistry; Duke University
- Postdoctoral training; Molecular Biology & Genetics; Massachusetts General Hospital/Harvard Medical School
- Postgraduate certificate; Clinical Pharmacology, Drug Development, and Regulation; Tufts University Center for the Study of Drug Development